Meeting BMI Requirements for Prescription Weight Loss Medication FDA-approved GLP-1 medications for weight loss are typically indicated for: Adults with obesity, defined as a body mass index of 30 or higher Adults with overweight, defined as a BMI of 27 or higher, who also have at least one weight-related medical condition A healthcare provider can confirm whether these criteria apply to your situation
P = 0.0006), and dulaglutide in REWIND trial (HR 0.88
LEfSe analysis provided a secondary measure to establish differences between treatment groups in addition to the one-way ANOVA/KruskalWallis tests performed on each genus/phylum
Identity may be assessed through complementary methods such as mass spectrometry, chromatographic analysis and comparison with established reference information
Dreyer RP, Xu X, Zhang W, Du X, Strait KM, Bierlein M, Bucholz EM, Geda M, Fox J, D'Onofrio G, Lichtman JH, Bueno H, Spertus JA, Krumholz HM